Interestingly, TP53 [24], TTN [25], PTEN [26], and EGFR [27] occupied the top four positions in both low-risk and high-risk groups, and they are interacting with each other to regulate various biological processes related to GBM, suggesting that they may be involved in tumor deterioration. The gene discussed is TP53; the disease is glioblastoma.